Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population. Despite therapeutic ...

Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population.

Very high lipoprotein(a) levels strongly predicted long-term cardiovascular disease risk in healthy women, according to a cohort study, while mild to moderately high levels were not really red flags.

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A.

If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease. But, ...

Higher lipoprotein(a) (Lp[a]) levels are associated with greater baseline coronary artery plaque burden and faster long-term plaque progression. Studies of Lp(a)-lowering therapies are underway.

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) [Lp(a)] levels and cardiovascular disease (CVD) in women and raises questions about whether broader ...

DEAR DR. ROACH: I’m a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn’t need to be ...

Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk. Higher cholesterol variability correlates with a greater incidence of dementia ...